References
Abu-Rustum, N.R., Alektiar, K., Iasonos, A., Lev, G., Sonoda, Y., Aghajanian, C., et al. (2006). The incidence of lower-extremity lymph-edema following treatment of uterine corpus malignancies: A 12 year experience at Memorial Sloan-Kettering Cancer Center. Gynecologic Oncology, 103, 714-718.
Armer, J.M., & Porock, D. (2002). Self-management of fatigue among women with lymph-edema. Lymphology, 35(Suppl.), 208-213.
Armer, J.M., Radina, M.E., Porock, D., & Culbertson, S.D. (2003). Predicting breast cancer-related lymphedema using self-reported symptoms. Nursing Research, 52, 370-379.
Beesley, V., Janda, M., Eakin, E., Obermair, A., & Battistutta, D. (2007). Lymphedema after gynecological cancer treatment: Prevalence, correlates, and supportive care needs. Cancer, 109, 2607-2614.
Brewer, V.H., Hahn, K.A., Rohrbach, B.W., Bell, J.L., & Baddour, L.M. (2000). Risk factor analysis for breast cellulitis complicating breast conservation therapy. Clinical Infectious Diseases, 31, 654-659.
Casely-Smith, J., & Casely-Smith, J. (1997). Modern treatment for lymphedema (5th ed.). Adelaide, Australia: Bowden Printing.
Cheville, A.L., McGarvey, C.L., Petrek, J.A., Russo, S.A., Thadiens, S.R., & Taylor, M.E. (2003). Lymphedema management. Seminars in Radiation Oncology, 13, 214-225.
Foldi, E. (1998). The treatment of lymphedema. Cancer, 83(Suppl. 12), 2833-2834.
International Society of Lymphology. (2003). The diagnosis and treatment of peripheral lymphedema: Consensus document of the International Society of Lymphology. Lymphology, 36(2), 84-91.
Kwan, W., Jackson, J., Weir, L.M., Dingee, C., McGregor, G., & Olivotto, I.A. (2002). Chronic arm morbidity after curative breast cancer treatment: Prevalence and impact on quality of life. Journal of Clinical Oncology, 20, 4242-4248.
Lerner, R. (1998). Complete decongestive physiotherapy and the Lerner Lymphedema Services Academy of Lymphatic Studies. Cancer, 83(Suppl. 12), 2861-2863.
Mortimer, P.S. (1998). The pathophysiology of lymphedema. Cancer, 83(Suppl. 12), 2798-2802.
National Lymphedema Network. (2005). The National Lymphedema Network. Retrieved August 11, 2007, from
http://www.lymphnet.org
Nunns, D., Williamson, K., Swaney, L., & Davy, M. (2000). The morbidity of surgery and adjuvant radiotherapy in the management of endometrial carcinoma. International Journal of Gynecologic Cancer, 10, 233-238.
Ridner, S.H. (2002). Breast cancer lymphedema: Pathophysiology and risk reduction guidelines. Oncology Nursing Forum, 29, 1285-1293.
Ryan, M., Stainton, M.C., Jaconelli, C., Watts, S., Mackenzie, P., Mansberg, T., et al. (2003). The experience of lower limb lymphedema for women after treatment for gynecologic cancer. Oncology Nursing Forum, 30, 417-423.
Ryan, M., Stainton, M.C., Slaytor, E.K., Jaconelli, C., Watts, S., & Mackenzie, P. (2003). Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer. Australia and New Zealand Journal of Obstetrics and Gynaecology, 43, 148-151.
Tobin, M.B., Lacey, H.J., Meyer, L., & Mortimer, P.S. (1993). The psychological morbidity of breast cancer-related arm swelling. Cancer, 72, 3248-3252.
Foldi, E. (1998). The treatment of lymphedema. Cancer, 83(Suppl. 12), 2833-2834.
International Society of Lymphology. (2003). The diagnosis and treatment of peripheral lymphedema: Consensus document of the International Society of Lymphology. Lymphology, 36(2), 84-91.
Mortimer, P.S. (1998). The pathophysiology of lymphedema. Cancer, 83(Suppl. 12), 2798-2802.